Ethical and policy issues in pediatric genetics

American Journal of Medical Genetics, Part C: Seminars in Medical Genetics

Volumn 148, Issue 1, 2008, Pages 1-7

  Ross, Lainie Friedman ^a,b,c  

^a Departments of Medicine and Pediatrics

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF CHICAGO   (United States)

Author keywords

Biobanks; Genetic testing; Informed consent; Late onset conditions; Longitudinal research; Newborn screening; Predictive genetic testing

Indexed keywords

CHILD HEALTH; DECISION MAKING; DUCHENNE MUSCULAR DYSTROPHY; FRAGILE X SYNDROME; GENE INTERACTION; GENETIC DISORDER; GENETICS; HEALTH CARE; HEALTH HAZARD; HEALTH PROGRAM; HUMAN; LYSOSOME STORAGE DISEASE; MEDICAL RESEARCH; MEDICAL SOCIETY; MORBIDITY; MORTALITY; NEWBORN SCREENING; PRIORITY JOURNAL; REVIEW; TANDEM MASS SPECTROMETRY;

BIOLOGICAL SPECIMEN BANKS; ETHICAL ANALYSIS; GENETIC DISEASES, INBORN; GENETIC RESEARCH; GENETIC SCREENING; HUMANS; INFANT, NEWBORN; INFORMED CONSENT; LONGITUDINAL STUDIES; PEDIATRICS; PREDICTIVE VALUE OF TESTS; PUBLIC POLICY;

EID: 39749198202     PISSN: 15524868     EISSN: 15524876     Source Type: Journal    
DOI: 10.1002/ajmg.c.30162     Document Type: Review

References (62)

1. American Society of Human Genetics (ASHG)/American College of Medical Genetics (ACMG). 1995. Points to consider: Ethical, legal, and psychosocial implications of genetic testing in children and adolescents. Am J Hum Genet 57:1233-1241.
2. American College of Medical Genetics (ACMG)/Health Resources and Services Administration (HRSA). ACMG/HRSA. 2005. Newborn Screening: Toward a Uniform Screening Panel and System. On the web at: ftp://ftp.hrsa.gov/mchb/genetics/ screeningnoappendices.pdf
3. Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. 2004. On the web at: http://mchb.hrsa.gov/programs/ genetics/committee/.
4. American Academy of Pediatrics (AAP) Committee on Bioethics. 2001. Ethical issues with genetic testing in pediatrics. Pediatrics 107:1451-1455.
5. Andrews L, Fullarton J, Holtzman N, Motulsky G, editors. 1994. Assessing genetic risks: Implications for health and social policy. Washington, DC: National Academy Press.
6. Association of Public Health Laboratories. 2002. Parental Consent in Public Health Newborn Screening Programs. On the web at: http://www.aphl.org/ policy/position_statements/Documents/ Parental_Consent_in_Newborn_Screening_Programs.pdf.
7. Atkinson K, Zuckerman B, Sharfstein JM, Levin D, Blatt RJ, Koh HK. 2001. A public health response to emerging technology: Expansion of the Massachusetts newborn screening program. Public Health Rep 116:122-131.
8. Bookman EB, Langehorne AA, Eckfeldt JH, Glass KC, Jarvik GR Klag M, Koski G, Motulsky A, Wilfond B, Manolio TA, Fabsitz RR, Luepker RV, NHLBI Working Group. 2006. Reporting genetic results in research studies: Summary and recommendations of an NHLBI working group. Am J Med Genet Part A 140A:1033-1040.
9. Borry P, Stultiens L, Nys H, Cassiman JJ, Dierickx K. 2006. Presymptoniatic and predictive genetic testing in minors: A systematic review of guidelines and position papers. Clin Genet 70:374-381.
10. Borry P, Goffin T, Nys H, Dierickx K. 2008. Attitudes regarding predictive genetic testing m minors. A Survey of European Clinical Geneticists. Am J Med Genet Part C Semin Med Genet (in press).
11. Botkin JR. 2005. Research for newborn screening: Developing a national framework. Pediatrics 116:862-871.
12. Botkin JR. 2008. Parental permission for research in newborn screening. In: Baily MA, Murray T, editors. Ethics and newborn genetic screening: New technologies, new forces, new challenges. Baltimore, MD: Johns Hopkins University Press (in press).
13. Botkin JR, Clayton EW, Fost NC, Burke W, Murray TH, Baily MA, Wilfond B, Berg A, Ross LE 2006. Newborn screening technology: Proceed with caution. Pediatrics 117:1793-1799.
14. Bradbury AR, Patrick-Miller L, Pawlowski K, Ibe CN, Cummings SA, Olopade OI, Daugherty CK. 2008. Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring. Am J Med Genet Part C Semin Med Genet (in press).
15. Braude P. 2006. Preimplantation diagnosis for genetic susceptibility. N Engl J Med 355:541-543.
16. Clarke AJ, editor. 1998. The genetic testing of children. Oxford UK: Bios Scientific Publishers Ltd.
17. Committee for the Study of Inborn Errors of Metabolism, National Research Council. 1975. Genetic screening: Programs, principles and research. Washington, DC: National Academy of Sciences.
18. Duncan RE, Gillam L, Savulescu J, Williamson R, Rogers JG, Delatycki MB. 2008. "You're one of us now": Young people describe their experiences of predictive genetic testing for Huntington disease (HD) and familial adenomatous polyposis (FAP). Am J Med Genet Part C Semin Med Genet (in press).
19. Elstad JI. 2005. Childhood adversities and health variations among middle-aged men: A retrospective lifecourse study. Eur J Public Health 15:51-58.
20. Faden R, Chwalow AJ, Holtzman NA, Horn SD. 1982. A survey to evaluate parental consent as public policy for neonatal screening. Am J Public Health 72:1347-1352.
21. Feuchtbaum L, Cunningham GC, Sciortino S. 2007. Questioning the need for informed consent: A case study of California's experience with a pilot newborn screening research project. J Empirical Res Hum Res Ethics 2:3-14.
22. Fost N, Farrell PM. 1989. A prospective randomized trial of early diagnosis and treatment of cystic fibrosis: A unique ethical dilemma. Clin Res 37:495-500.
23. Gaston MH, Verter JI, Woods G, Pegelow C, Kelleher J, Presbury G, Zarkowsky H, Vichinsky E, Iyer R, Lobel JS, Diamond S, Holbrook CT, Gill FM, Ritchey K, Falletta JM, for the Prophylactic Penicillin Study Group. 1986. Prophylaxis with oral penicillin in children with sickle cell anemia: A randomized trial. N Engl J Med 314:1593-1599.
24. Grosse SD, Olney RS, Baily MA. 2005. The cost effectiveness of universal versus selective newborn screening for sickle cell disease in the US and the UK: A critique. Appl Health Econ Health Policy 4:239-247.
25. Grosse SD, Boyle CA, Kenneson A, Khoury MJ, Wilfond BS. 2006. From public health emergency to public health service: The implications of evolving criteria for newborn screening panels. Pediatrics 117:923-929.
26. Human Genetics Commission (UK). 2005. Profiling the newborn: A prospective gene technology? Human Genetics Commission document. On the web at: http://www.hgc.gov.uk/UploadDocs/Contents/Documents/ Final%20Draft%20of%20Profiling%20Newborn%20Report%2003%2005.pdf.
27. Jenkins MM, Rasmussen SA, Moore CA, Honein MA. 2008. Ethical issues raised by incorporation of genetics into the national birth defects prevention study. Am J Med Genet Part C Semin Med Genet (in press).
28. Kaiser J. 2006. Genetics. U. S. hospital launches large biobank of children's DNA. Science 312:1584-1585.
29. Kaufman D, Geller G, LeRoy L, Murphy J, Scott J, Hudson K. 2008. Ethical implications of including children in a large biobank for genetic-epidemiologic research: A qualitative study of public opinion. Am J Med Genet Part C Semin Med Genet (in press).
30. Kavanagh PL, Wang CJ, Bauchner H, Sprinz PG, Therrell BL. 2008. Communication of positive newborn screening results for sickle cell disease and sickle cell trait: Variation across states. Am J Med Genet Part C Semin Med Genet (in press).
31. Kestila L, Koskinen S, Martelin T, Rahkonen O, Pensola T, Aro H, Aromaa A. 2006. Determinants of health in early adulthood: What is the role of parental education, childhood adversities and own education? Eur J Public Health 16:306-315.
32. Kodish ED. 1999. Testing children for cancer genes: The rule of earliest onset. J Pediatr 135:390-395.
33. Kohane IS, Mandl KD, Taylor PL, Holm IA, Nigrin DJ, Kunkel LM. 2007. Medicine. Reestablishing the researcher-patient compact. Science 316:836-837.
34. Levy D. 2005. Community Concerns Regarding Genomic Research and Data Sharing: Adding Genome-wide Association to Population Studies. Powerpoint presentation on the web at: http://www.genome.gov/Multimedia/OD/GWAS_Boston_07/ 10-Levy_Community.ppt.
35. Levy HL, Cornier AS. 1994. Current approaches to genetic metabolic screening in newborns. Curr Opin Pediatr 6:707-711.
36. Louey S, Thornburg KL. 2005. The prenatal environment and later cardiovascular disease. Early Hum Dev 81:745-751.
37. McConkie-Rosell A, Spindigliozzi GA, Melvin E, Dawson DV, Lachiewicz AM. 2008. Living with genetic risk: Effect on adolescent self-concept. Am J Med Genet Part C Semin Med Genet (in press).
38. National Children's Study. Updated October 17, 2007. http://www. nationalchildrensstudy.gov/.
39. National Heart Lung, Blood Institute (NHLBI) Communications Office. 2005. Framingham Heart Study Enters New Phase. On the web at: http://findarticles. com/p/articles/mi_pnih/is_200111/ai_3832493828.
40. National Institutes of Health Consensus Development Conference. 1987. Newborn screening for sickle cell disease and other hemoglobinopathies. NIH Consensus Statement 1987 6:1-22.
41. National Newborn Screening and Genetics Resource Center. 2003. National Newborn Screening Report: 2000. Austin, TX. On the web at: http://www. regenstrief.org/medinformatics/loinc/meetings/20040312/laboratory-loinc-meeting- 03-12-2004/handout-i.pdf
42. National Newborn Screening and Genetics Resource Center. 2007. National Newborn Screening Status Report. Updated October 17, 2007. On the web at: http://genes-r-us.uthscsa.edu/nbsdisorders.pdf.
43. Natowicz M. 2005. Newborn screening - Setting evidence-based policy for protection. N Engl J Med 353:867-870.
44. Offit K, Sagi M, Hurley K. 2006. Preimplantation genetic diagnosis for cancer syndromes: A new challenge for preventive medicine. JAMA 296:2727-2730.
45. Pandor A, Eastham J, Beverley C, Chicott J, Paisley S. 2004. Clinical effectiveness and cost-effectiveness of neonatal screening for inborn errors of metabolism using tandem mass spectrometry: A systematic review. Health Technology Assessment 8:1-134.
46. Panepinto JA, Magid D, Rewers MJ, Lane PA. 2000. Universal versus targeted screening of infants for sickle cell disease: A cost-effectiveness analysis. J Pediatr 136:201-208.
47. Pass K, Green NS, Lorey F, Sherwin J, Comeau AM. 2006. Pilot programs in newborn screening. Ment Retard Dev Disabil Res Rev 12:293-300.
48. Paul DB. 2008. Patient Advocacy in Newborn Screening: Continuities and Discontinuities. Am J Med Genet Part C Semin Med Genet (in press).
49. Phoenix DD, Lybrook SM, Trottier RW, Hodgin FC, Crandall LA. 1995. Sickle cell screening policies as portent: How will the human genome project affect public sector genetic services? J Natl Med Assoc 87:807-812.
50. Pollitt RJ. 2007. Introducing new screens: Why are we all doing different things? J Inherit Metab Dis 30:423-429.
51. Pollitt RJ, Green A, McCabe CJ, Booth A, Cooper NJ, Leonard JV, Nicholl J, Nicholson P, Tunaley JR, Virdi NK. 1997. Neonatal screening for inborn errors of metabolism: Cost, yield, and outcome. Health Technology Assessment 1:1-202.
52. Ravitsky V, Wilfond BS. 2006. Disclosing individual genetic results to research participants. Am J Bioethics 6:8-17.
53. Reilly P. 1977. Genetics, law, and social policy. Cambridge, MA: Harvard University Press.
54. Ross LF. 2002. Predictive genetic testing for conditions that present in childhood. Kennedy Inst Ethics J 12:225-244.
55. Shalowitz DI, Miller FG. 2005. Disclosing individual results of clinical research: Implications of respect for participants. JAMA 294:737-740.
56. Sprinkle RH, Hynes DM, Konrad TR. 1994. Is universal neonatal hemoglobinopathy screening cost-effective? Arch Pediatr Adolesc Med 148:461-469.
57. Stadler SC, Polanetz R, Maier EM, Heidenreich SC, Niederer B, Mayerhofer PU, Lagler F, Koch HG, Santer R, Fletcher JM, Ranieri E, Das AM, Spiekerkotter U, Schwab KO, Potzseh S, Marquardt I, Hennermann JB, Knerr I, Mercimek-Mahmutoglu S, Kohlschmidt N, Liebl B, Fingerhut R, Olgemoller B, Muntau AC, Roscher AA, Roschinger W 2006. Newborn screening for 3-methylcrotonyl-CoA carboxylase deficiency: Population heterogeneity of MCCA and MCCB mutations and impact on risk assessment. Hum Mutat 27:748-759.
58. Tarini BA, Burke W, Scott CR, Wilfond BS. 2008. Waiving informed consent in newborn screening research: Balancing social value and respect. Am J Med Genet Part C Semin Med Genet (in press).
59. Tsevat J, Wong JB, Pauker SG, Steinberg MH. 1991. Neonatal screening for sickle cell disease: A cost-effectiveness analysis. J Pediatr 118:546-554.
60. Viner RM, Taylor B. 2005. Adult health and social outcomes of children who have been in public care: Population-Based Study. Pediatrics 115:894-899.
61. Whalley LJ, Dick FD, McNeill G. 2006. A life-course approach to the aetiology of late-onset dementias. Lancet Neurol 5:87-96.
62. Working Party of the Clinical Genetics Society (UK). 1994. The genetic testing of children. J Med Genet 31:785-797.